160 related articles for article (PubMed ID: 37015905)
1. L1CAM deployed perivascular tumor niche promotes vessel wall invasion of tumor thrombus and metastasis of renal cell carcinoma.
Wu Z; Wu Y; Liu Z; Song Y; Ge L; Du T; Liu Y; Liu L; Liu C; Ma L
Cell Death Discov; 2023 Apr; 9(1):112. PubMed ID: 37015905
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.
Bondong S; Kiefel H; Hielscher T; Zeimet AG; Zeillinger R; Pils D; Schuster E; Castillo-Tong DC; Cadron I; Vergote I; Braicu I; Sehouli J; Mahner S; Fogel M; Altevogt P
Ann Oncol; 2012 Jul; 23(7):1795-802. PubMed ID: 22228447
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.
Liu Z; Li Y; Zhao X; Ge L; Zhu G; Hong P; Tang S; Zhang S; Tian X; Wang S; Liu C; Zhang H; Ma L
BMC Surg; 2021 Dec; 21(1):443. PubMed ID: 34963464
[TBL] [Abstract][Full Text] [Related]
4. Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.
Issa Y; Nummer D; Seibel T; Müerköster SS; Koch M; Schmitz-Winnenthal FH; Galindo L; Weitz J; Beckhove P; Altevogt P
J Mol Med (Berl); 2009 Jan; 87(1):99-112. PubMed ID: 18931829
[TBL] [Abstract][Full Text] [Related]
5. Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth.
Weinspach D; Seubert B; Schaten S; Honert K; Sebens S; Altevogt P; Krüger A
Clin Exp Metastasis; 2014 Jan; 31(1):87-100. PubMed ID: 24002299
[TBL] [Abstract][Full Text] [Related]
6. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion.
Li Y; Galileo DS
Cancer Cell Int; 2010 Sep; 10():34. PubMed ID: 20840789
[TBL] [Abstract][Full Text] [Related]
7. Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study.
Wang BS; Li YZ; Fang YY; Zhang SD; Ma LL
Chin Med J (Engl); 2020 Sep; 133(17):2078-2083. PubMed ID: 32898352
[TBL] [Abstract][Full Text] [Related]
8. Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma.
Wallace A; Porten SP; Lo AA; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Zill OA; Meng MV
Mol Cancer Res; 2022 Jun; 20(6):909-922. PubMed ID: 35297992
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
Kim JH; Lee KW; Ahn DG; Oh KY; Yoon HJ
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825596
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma.
Huang CS; Tang SJ; Lee MH; Chang Wang CC; Sun GH; Sun KH
J Cell Mol Med; 2018 Dec; 22(12):5909-5918. PubMed ID: 30246456
[TBL] [Abstract][Full Text] [Related]
11. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
[TBL] [Abstract][Full Text] [Related]
12. The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma.
Mestas J; Burdick MD; Reckamp K; Pantuck A; Figlin RA; Strieter RM
J Immunol; 2005 Oct; 175(8):5351-7. PubMed ID: 16210641
[TBL] [Abstract][Full Text] [Related]
13. L1CAM: a major driver for tumor cell invasion and motility.
Kiefel H; Bondong S; Hazin J; Ridinger J; Schirmer U; Riedle S; Altevogt P
Cell Adh Migr; 2012; 6(4):374-84. PubMed ID: 22796939
[TBL] [Abstract][Full Text] [Related]
14. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC).
Weiss VL; Braun M; Perner S; Harz A; Vorreuther R; Kristiansen G; Müller SC; Ellinger J
BJU Int; 2014 Feb; 113(2):209-17. PubMed ID: 24053185
[TBL] [Abstract][Full Text] [Related]
16. Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.
Morin E; Lindskog C; Johansson M; Egevad L; Sandström P; Harmenberg U; Claesson-Welsh L; Sjöberg E
J Pathol; 2020 Apr; 250(4):387-396. PubMed ID: 31880322
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of renal collecting system invasion on survival of patients with renal cell carcinoma and tumor thrombus.
Przydacz M; Golabek T; Okon K; Dudek P; Chlosta P
Cent European J Urol; 2020; 73(3):280-286. PubMed ID: 33133654
[TBL] [Abstract][Full Text] [Related]
18. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.
Cave DD; Hernando-Momblona X; Sevillano M; Minchiotti G; Lonardo E
Theranostics; 2021; 11(12):5686-5699. PubMed ID: 33897875
[No Abstract] [Full Text] [Related]
19. Diagnostic performance and prognostic value of preoperative
Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M
Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856
[TBL] [Abstract][Full Text] [Related]
20. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
